“The most at risk,” states WHO, “are, once again, the poorest, who sometimes think it is a good bargain when they buy what seems to be an efficient medicine produced by a respectable company.”
“Minsan pa,” sabi ng WHO, “lubhang nanganganib ang pinakamahirap, na kung minsan ay nag-iisip na nakatitipid sila kung bibili sila ng tila ba isang mabisang gamot na gawa ng isang iginagalang na kompanya.”jw2019 jw2019